{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/parkinsons-disease/how-up-to-date-is-this-topic/update/","result":{"pageContext":{"chapter":{"id":"e1bb005f-8b49-5ae3-9670-a888d5def19a","slug":"update","fullItemName":"Update","depth":2,"htmlHeader":"<!-- begin field 30be7ff1-904a-4434-a401-a55efe7c4010 --><h2>Update</h2><!-- end field 30be7ff1-904a-4434-a401-a55efe7c4010 -->","summary":null,"htmlStringContent":"<!-- begin item a11c6b13-1dd6-42f7-bd08-f11559ce1ec5 --><!-- end item a11c6b13-1dd6-42f7-bd08-f11559ce1ec5 -->","topic":{"id":"6cfe5031-c78a-5fcf-8597-8688ef0d3a41","topicId":"ac61656d-8e8b-48b8-bf1d-49f506afadb6","topicName":"Parkinson's disease","slug":"parkinsons-disease","lastRevised":"Last revised in February 2018","chapters":[{"id":"8bebf6b8-3a72-530a-ac48-52a8618f2267","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"044ab1d2-584c-5ed9-ab24-f7c8d64ef959","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"51b4e173-4f8a-5f7a-9e4a-fff68f32b031","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"29a7b8ce-d32b-5e9d-a682-56084e34b727","slug":"changes","fullItemName":"Changes"},{"id":"e1bb005f-8b49-5ae3-9670-a888d5def19a","slug":"update","fullItemName":"Update"}]},{"id":"fbbb2e6c-5309-5aa6-a27f-d6f508b6f994","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"40c62f24-40c5-5619-88aa-963a7de0d17d","slug":"goals","fullItemName":"Goals"},{"id":"2b0ddbc1-3535-545a-8be3-996ce778ee4d","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"a8f322a5-4ac1-50c9-8391-83584bd86b30","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"d2a1f92e-43cd-575e-bcbd-7bd0e6792634","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"e860c3e6-3288-5ee1-bd77-a6d4aa0c3006","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"d3463e24-bbaa-5d3a-aca9-0d6da87a47f3","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"644e166b-8434-55a7-859c-6479b609051a","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"935e4ed2-12f3-5857-9a26-8a3beaed429c","slug":"definition","fullItemName":"Definition"},{"id":"58a49a4b-fb27-55f3-9afb-3c816842a76a","slug":"prevalence","fullItemName":"Prevalence"},{"id":"ce592a68-6b1f-5015-8125-2facfdcc4afe","slug":"prognosis","fullItemName":"Prognosis"},{"id":"8a05334f-9e7a-5662-b166-d86bd3c7546e","slug":"complications","fullItemName":"Complications"}]},{"id":"3951c9c0-49fe-5d17-8d1d-4c42b0b95c3f","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"e7662ffa-e42d-5bb5-9025-2ba5f6587a6f","slug":"when-to-suspect","fullItemName":"When to suspect"},{"id":"435dc95c-73c1-5636-953b-feb3d7f82aaf","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"196d12bb-51bd-5a0b-872d-c7b60bde431b","fullItemName":"Management","slug":"management","subChapters":[{"id":"38b7e750-e77e-5791-a127-6e5192b69597","slug":"suspected-parkinsons-disease","fullItemName":"Scenario: Suspected Parkinson's disease"},{"id":"fae10e1b-26bc-523c-bc3b-ec45e56860ca","slug":"confirmed-parkinsons-disease","fullItemName":"Scenario: Confirmed Parkinson's disease"},{"id":"c0adefb6-a71d-5b3c-bc2d-b86a13219e16","slug":"end-stage-parkinsons-disease","fullItemName":"Scenario: End-stage Parkinson's disease"}]},{"id":"d811822d-b022-5b69-8514-00e15d349643","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"83038956-9818-52c8-9415-85ab073e43aa","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"757d939c-8a84-5a32-847b-38d850b38230","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"17a6cb12-1c93-5aff-bc74-2c2cee2f97ee","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"bd851d10-0cce-5204-8b2e-54ae60c5767f","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"9d232b23-7764-59d5-8026-50fff91a905b","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"7deed303-b70d-5459-8ca1-d40e9dbf3c88","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"1a717fd3-80b2-587f-8d46-3f904380d76a","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"51b4e173-4f8a-5f7a-9e4a-fff68f32b031","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"0f626ac7-1e82-5e6c-9f29-7a2dae1a3001","slug":"new-evidence","fullItemName":"New evidence","depth":3,"htmlHeader":"<!-- begin field 8ba513ce-385a-4a20-95a5-ecdbe0ff310e --><h3>New evidence</h3><!-- end field 8ba513ce-385a-4a20-95a5-ecdbe0ff310e -->","summary":null,"htmlStringContent":"<!-- begin item 6d600afd-e6a7-456e-8b4b-a40ca1904077 --><!-- begin field e36af24a-8436-47c3-b222-9c942ae2ed33 --><h3>Evidence-based guidelines</h3><!-- end field e36af24a-8436-47c3-b222-9c942ae2ed33 --><!-- begin field 501d303d-01a4-46b3-adc4-b45a04adda3f --><ul><li>NICE (2018)<em> Parkinsons disease QS164.</em> National Institute for Health and Care Excellence. <a href=\"https://www.nice.org.uk/\" data-hyperlink-id=\"6f33627b-aa83-4b93-a263-a8f7014b1764\">www.nice.org.uk</a> [<a href=\"https://www.nice.org.uk/guidance/qs164\" data-hyperlink-id=\"fd3796ff-27e7-48ee-b3d1-a8f7014b1776\">Free full text</a>]</li><li>de Bie, R.M.A., Clarke, C.E., Espay, A.J. et al (2020)<em> Initiation of pharmacological therapy in Parkinson's disease: when, why and how</em>. Lancet Neurology. <a href=\"https://www.thelancet.com/\" data-hyperlink-id=\"1cd13ec2-5773-4064-9afc-ab8800983745\">www.thelancet.com</a> [<a href=\"https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(20)30036-3/fulltext\" data-hyperlink-id=\"55496b84-180f-4308-9ece-ab8800983db0\">Abstract</a>]</li></ul><!-- end field 501d303d-01a4-46b3-adc4-b45a04adda3f --><!-- begin field 24b6b6f5-a197-400f-bdc8-e0ce9ab2fe80 --><h3>HTAs (Health Technology Assessments)</h3><!-- end field 24b6b6f5-a197-400f-bdc8-e0ce9ab2fe80 --><!-- begin field 0a7485ed-b8dc-46e0-9e67-9cff2e6b8e6c --><p>No new HTAs since 1 January 2018.</p><!-- end field 0a7485ed-b8dc-46e0-9e67-9cff2e6b8e6c --><!-- begin field c6268570-bb0a-4725-907c-95463e202133 --><h3>Economic Appraisals</h3><!-- end field c6268570-bb0a-4725-907c-95463e202133 --><!-- begin field 8b5090dc-1ba6-4152-8d69-7f639644dddc --><p>No new economic appraisals relevant to England since 1 January 2018.</p><!-- end field 8b5090dc-1ba6-4152-8d69-7f639644dddc --><!-- begin field 1e28e164-83cc-4a65-a80a-5278f2ae6346 --><h3>Systematic reviews and meta-analyses</h3><!-- end field 1e28e164-83cc-4a65-a80a-5278f2ae6346 --><!-- begin field d13e29c3-30fe-4bc8-933f-925aa3a0a511 --><ul><li>Marinus, J., et al. (2018) <em>Risk factors for non-motor symptoms in Parkinson's disease. </em><a data-hyperlink-id=\"b3fb2c25-3a6a-43f4-895a-a8f70151437f\" href=\"https://www.thelancet.com/\">www.thelancet.com</a> [<a data-hyperlink-id=\"a672118f-711a-4f62-ae39-a8f701514e35\" href=\"https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(18)30127-3/fulltext\">Free Full-text</a>]</li><li>The Lancet Neurology (2018) Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology. <a href=\"https://www.thelancet.com/\" data-hyperlink-id=\"48a1dd2f-b3c3-4501-95ac-a97000ddb4c5\">www.thelancet.com</a> [<a href=\"https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(18)30295-3/fulltext\" data-hyperlink-id=\"68beb072-751f-4526-b066-a97000dde1ff\">Free Full-text</a>]</li></ul><!-- end field d13e29c3-30fe-4bc8-933f-925aa3a0a511 --><!-- begin field 105dac5b-fd67-4953-8df4-67e65668c58d --><h3>Primary evidence</h3><!-- end field 105dac5b-fd67-4953-8df4-67e65668c58d --><!-- begin field e475776a-6a2e-40af-b08f-6870df473f70 --><ul><li>NIHR Signal (2019)<em> When is it best to start the Parkinson’s drug, levodopa?</em> NIHR Signal. <a href=\"https://discover.dc.nihr.ac.uk/portal/home\" data-hyperlink-id=\"eecb7625-240e-47e4-a272-aa3f00ce2ca7\">www.discover.dc.nihr.ac.uk</a> [<a href=\"https://discover.dc.nihr.ac.uk/content/signal-000761/when-is-it-best-to-start-the-parkinsons-drug-levodopa\" data-hyperlink-id=\"5abf6c32-dee2-40e5-86ba-aa3f00ce2cf8\">Free Full-text</a>]</li></ul><!-- end field e475776a-6a2e-40af-b08f-6870df473f70 --><!-- end item 6d600afd-e6a7-456e-8b4b-a40ca1904077 -->","subChapters":[]},{"id":"b8269c04-6b5a-5c49-a726-939f4cf7796e","slug":"new-policies","fullItemName":"New policies","depth":3,"htmlHeader":"<!-- begin field 4e681ab3-0bd2-4867-9045-15428b9dae31 --><h3>New policies</h3><!-- end field 4e681ab3-0bd2-4867-9045-15428b9dae31 -->","summary":null,"htmlStringContent":"<!-- begin item 6fa0b94c-cc69-48ce-ade6-02ee83255340 --><!-- begin field c14f3e2b-5d34-40e1-8efa-7bc219f4a4f8 --><p>No new national policies or guidelines since 1 January 2018.</p><!-- end field c14f3e2b-5d34-40e1-8efa-7bc219f4a4f8 --><!-- end item 6fa0b94c-cc69-48ce-ade6-02ee83255340 -->","subChapters":[]},{"id":"19de29b8-90dd-56d3-9f9a-02a8f534a1c8","slug":"new-safety-alerts","fullItemName":"New safety alerts","depth":3,"htmlHeader":"<!-- begin field e5ce7ed5-00bd-40b8-b55e-1cc15ddb92dc --><h3>New safety alerts</h3><!-- end field e5ce7ed5-00bd-40b8-b55e-1cc15ddb92dc -->","summary":null,"htmlStringContent":"<!-- begin item 820eaae6-5f41-49d4-8b0b-00c3800cdf00 --><!-- begin field 5966bf56-81cc-4b7b-8ffb-3e682b976556 --><p>No new safety alerts since 1 January 2018.</p><!-- end field 5966bf56-81cc-4b7b-8ffb-3e682b976556 --><!-- end item 820eaae6-5f41-49d4-8b0b-00c3800cdf00 -->","subChapters":[]},{"id":"90c420b1-1c8b-528c-9055-941cacdc7369","slug":"changes-in-product-availability","fullItemName":"Changes in product availability","depth":3,"htmlHeader":"<!-- begin field 5b80cb23-572e-49bb-9967-0ec96b032793 --><h3>Changes in product availability</h3><!-- end field 5b80cb23-572e-49bb-9967-0ec96b032793 -->","summary":null,"htmlStringContent":"<!-- begin item 17dcbd8c-ddea-452d-a17b-17d729e28edb --><!-- begin field 9e2a23f4-a691-4ecb-aa70-2cecd754b038 --><p>No changes in product availability since 1 January 2018.</p><!-- end field 9e2a23f4-a691-4ecb-aa70-2cecd754b038 --><!-- end item 17dcbd8c-ddea-452d-a17b-17d729e28edb -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}